These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8298128)

  • 1. The macrocyclic lactone protein kinase C activator, bryostatin 1, either alone, or in conjunction with recombinant murine granulocyte-macrophage colony-stimulating factor, protects Balb/c and C3H/HeN mice from the lethal in vivo effects of ionizing radiation.
    Grant S; Traylor R; Pettit GR; Lin PS
    Blood; 1994 Feb; 83(3):663-7. PubMed ID: 8298128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S; Pettit GR; McCrady C
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination.
    Waddick KG; Song CW; Souza L; Uckun FM
    Blood; 1991 Jun; 77(11):2364-71. PubMed ID: 1710151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by bryostatin 1 of the in vitro radioprotective effects of the GM-CSF/IL-3 fusion protein, PIXY 321, on normal human myeloid progenitors.
    Grant S; Traylor R; Pettit GR; Lin PS
    Cytokine; 1993 Sep; 5(5):490-7. PubMed ID: 8142605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S; Pettit GR; Howe C; McCrady C
    Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF.
    McCrady CW; Staniswalis J; Pettit GR; Howe C; Grant S
    Br J Haematol; 1991 Jan; 77(1):5-15. PubMed ID: 1998597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S; Traylor R; Bhalla K; McCrady C; Pettit GR
    Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor.
    Li F; Grant S; Pettit GR; McCrady CW
    Blood; 1992 Nov; 80(10):2495-502. PubMed ID: 1421372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice.
    Uckun FM; Souza L; Waddick KG; Wick M; Song CW
    Blood; 1990 Feb; 75(3):638-45. PubMed ID: 1688721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotective effects of various cytokines in peripheral blood mononuclear cells and C3H mice.
    Kim JY; Oh SJ; Park HK; Yoon JS; Kim ES; Kim ES; Kim CS; Lee YY; Kim BK
    Oncol Rep; 2005 Jun; 13(6):1177-83. PubMed ID: 15870940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C activators can interact synergistically with granulocyte colony-stimulating factor or interleukin-6 to stimulate colony formation from enriched granulocyte-macrophage colony-forming cells.
    Heyworth CM; Dexter TM; Nicholls SE; Whetton AD
    Blood; 1993 Feb; 81(4):894-900. PubMed ID: 7679006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
    Klimp AH; Regts J; Scherphof GL; de Vries EG; Daemen T
    Br J Cancer; 1999 Jan; 79(1):89-94. PubMed ID: 10408698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
    Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
    Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
    Naparstek E; Ohana M; Greenberger JS; Slavin S
    Exp Hematol; 1993 Jan; 21(1):131-7. PubMed ID: 8417949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts.
    Grant S; Jarvis WD; Turner AJ; Wallace HJ; Pettit GR
    Br J Haematol; 1992 Nov; 82(3):522-8. PubMed ID: 1486032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
    Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
    Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin.
    Kalechman Y; Albeck M; Sredni B
    Cell Immunol; 1992 Aug; 143(1):143-53. PubMed ID: 1623562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antineoplastic bryostatins affect human basophils and mast cells differently.
    Patella V; Casolaro V; Ciccarelli A; Pettit GR; Columbo M; Marone G
    Blood; 1995 Mar; 85(5):1272-81. PubMed ID: 7532037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.